MEDIUMFDA DRUG

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
May 22, 2026
Status
ACTIVE
Severity
5/10

Quick Facts at a Glance

Recall Date
May 22, 2026
Hazard Level
MEDIUM
Brand
SUN PHARMACEUTICAL INDUSTRIES
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
SUN PHARMACEUTICAL INDUSTRIES
Product type
Rosuvastatin Tablets
Model numbers
Lot #: AE11393, Exp Date: 10/2027.
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    May 22, 2026

  2. Reported by FDA DRUG

    June 10, 2026

  3. RecallRadar source check

    June 17, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact SUN PHARMACEUTICAL INDUSTRIES INC or your healthcare provider for guidance. Notification method: Letter

About This Product

Rosuvastatin Tablets are prescription medications used to lower cholesterol levels in adults. They are often prescribed to reduce the risk of heart disease and related conditions.

Why This Is Dangerous

The dissolution issue means the tablets may not release the active ingredient as intended, potentially reducing effectiveness and safety.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers are advised to stop using the product immediately, which may cause inconvenience for those relying on the medication for cholesterol management.

Practical Guidance

How to identify if yours is affected

  1. Check the carton for the lot number #49124.
  2. Verify the expiration date on the packaging: 12/31/2026.
  3. Confirm that the product matches the description of the recalled Rosuvastatin Tablets.

Where to find product info

Look for the lot number and expiration date printed on the carton and individual tablet packaging.

What timeline to expect

Expect a refund or replacement process to take approximately 4-6 weeks after returning the product.

If the manufacturer is unresponsive

  • Document all interactions with AvKARE regarding the recall.
  • Consider reaching out again via different contact methods.
  • File a complaint with the FDA if necessary.

How to prevent similar issues

  • When purchasing medications, check for FDA recalls online.
  • Always verify the expiration dates and lot numbers of prescription medications.
  • Consult your healthcare provider if unsure about the safety of a medication.

Documentation advice

Keep records of purchase receipts, correspondence with the manufacturer, and any notes on side effects experienced.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves Rosuvastatin Tablets, USP, 10 mg. The product comes in 50 tablets per carton and was manufactured by AvKARE in Pulaski, TN. The affected lot number is #49124, and the expiration date is December 31, 2026.

Key Facts

  • Recall date: December 31, 2025
  • Reported date: January 14, 2026
  • Quantity recalled: 7,991 cartons
  • Product manufactured in Pulaski, TN
  • Lot number: #49124, Expiration: 12/31/2026

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelMEDIUM
Severity Score
5/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot #: AE11393
Exp Date: 10/2027.
Affected States
ALL
Report Date
June 10, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more